|H-89||Unit size||Cat. code||Docs||Qty||Price|
H-89 is a selective, potent cell permeable inhibitor of cAMP-dependent protein kinase (PKA).
PKA is involved in the TLR-mediated TREM-1 expression on macrophages following LPS stimulation [1,2].
PKA inhibition with H-89 can also reduce IL-6 expression by 50% .
1. Hu J et al. 2002. Regulation of IL-1 Receptor-Associated Kinases by Lipopolysaccharide1 J. Immunol. 168: 3910-3914.
2. Murakami Y. et al., 2007. Lipopolysaccharide-Induced Up-Regulation of Triggering Receptor Expressed on Myeloid Cells-1 Expression on Macrophages Is Regulated by Endogenous Prostaglandin E2. J. Immunol. 178: 44.
3. Weigert C. et al., 2003. Microarray expression analysis of mesangial cells overexpressing glucose transporters: marked increase in interleukin-6 production. Nephrol. Dial. Transplant. 18: 32-44.
Working concentration: 5 - 50 µM
Purity: >99% (HPLC)
CAS number: 127243-85-0
Synonym: 5-isoquinolinesulfonamide, 2HCl
Molecular weight: 519.3
Solubility: 50mg/ml in DMSO and ethanol, 25 mg/ml in H2O (heat to dissolve)Back to the top
H-89 is provided as a solid.
- 5 mg
H-89 is shipped at room temperature.
Store at -20 ̊C.
Solid product is stable 1 year at-20°C.Back to the top